Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
International Immunopharmacology (2021) - Comments
pubmed: 34426106  doi: 10.1016/j.intimp.2021.107961  issn: 1567-5769  issn: 1878-1705 

Atefeh Fakharian, Saghar Barati, Maryam Mirenayat, Mitra Rezaei, Sara Haseli, Pooria Torkaman, Sahar Yousefian, Alireza Dastan, Hamidreza Jamaati, Farzaneh Dastan